Drug-Eluting Stent Below The Knee - DES-BTK


Conventionally, infrapopliteal disease is treated with angioplasty alone, and sometimes with bare-metal stents (BMS). The DES-BTK trial sought to compare outcomes after sirolimus-eluting stenting (SES) versus BMS in patients with either intermittent claudication or critical limb ischemia (CLI) who had a de novo lesion up to 5 cm in length in an infrapopliteal artery.